Lia Eustachewich
Germany’s vaccine commission said AstraZeneca’s COVID-19 vaccine should not be used on people 65 and older due to “insufficient data” on its efficacy.
The Standing Vaccine
Commission said the shot, which is being developed with the University of
Oxford, should only be used on people aged 18 to 64 “based on available data.”
“There is currently
insufficient data to assess the efficacy of the vaccine for persons aged 65
years and older,” the panel of scientific experts said.
The recommendation follows
confusion earlier this week over the efficacy of AstraZeneca’s jab in adults
over 65.
Two German newspapers, citing
government sources, said the shot was found to be as low as 8 percent effective
in seniors — which the UK-based company said was “completely incorrect,” German broadcaster Deutsch Welle reported on Tuesday.
“In November, we published data in The Lancet demonstrating that older adults showed strong immune responses to the vaccine, with 100% of older adults generating spike-specific antibodies after the second dose,” AstraZeneca’s spokesperson said.
The startling statistic was
also refuted by the German Health Ministry, which suggested the leaks mixed up
the 8 percent figure.
“At first glance, it appears
that two things have been confused in the reports: About 8% of the
subjects in the AstraZeneca efficacy study were between 56 and 69 years of age,
and only 3 to 4% were over 70 years of age,” a spokesperson said.
“However, this does not infer
an efficacy of only 8% in the elderly.”
The European Medicines Agency
is expected to decide whether to approve AstraZeneca’s vaccine on Friday.
Lia Eustachewich, The New York Post, January 28, 2021 | 9:13am
Nenhum comentário:
Postar um comentário
Não publicamos comentários de anônimos/desconhecidos.
Por favor, se optar por "Anônimo", escreva o seu nome no final do comentário.
Não use CAIXA ALTA, (Não grite!), isto é, não escreva tudo em maiúsculas, escreva normalmente. Obrigado pela sua participação!
Volte sempre!
Abraços./-